
At Vitrue Health, we empower businesses to cultivate healthier, more productive workplaces by addressing health challenges before they arise. Our advanced solutions combine computer vision, biomechanics, and clinical decision-support technologies to tackle musculoskeletal (MSK) issues like back, neck, and shoulder pain—transforming employee wellbeing and employer compliance. With Vitrue Health, eliminate pain and elevate health, so your teams can stay focused, energised, and performing at their best.

At Vitrue Health, we empower businesses to cultivate healthier, more productive workplaces by addressing health challenges before they arise. Our advanced solutions combine computer vision, biomechanics, and clinical decision-support technologies to tackle musculoskeletal (MSK) issues like back, neck, and shoulder pain—transforming employee wellbeing and employer compliance. With Vitrue Health, eliminate pain and elevate health, so your teams can stay focused, energised, and performing at their best.
Focus: Computer-vision and AI platform for preventing and treating musculoskeletal (MSK) issues
Flagship product: VIDA — AI/computer-vision platform for MSK assessment, DSE compliance and personalised pathways
Founded / HQ: 2017, London (Vitrue Ltd)
Customers / scale: Reported use by 100k+ employees
Recent funding: Seed round closed Feb 29, 2024; lead investors MMC Ventures and Salica
Workplace and clinical musculoskeletal (MSK) assessment, prevention and treatment
2017
Health and Human Services
Crunchbase lists this Seed round closed Feb 29, 2024
“MMC Ventures; Salica; plus other disclosed investors including Crista Galli Ventures, Chris Bruce, Simplyhealth, Worth Capital and Cambridge Angels group”